• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人尿苷二磷酸葡萄糖醛酸转移酶与细胞色素 P450 选择性底物和抑制剂的抑制研究。

The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.

机构信息

Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Laboratory of Drug Metabolism & Pharmacokinetics, Science Park, Luo Gang District, Guangzhou, China.

出版信息

J Enzyme Inhib Med Chem. 2011 Jun;26(3):386-93. doi: 10.3109/14756366.2010.518965. Epub 2010 Oct 13.

DOI:10.3109/14756366.2010.518965
PMID:20939765
Abstract

Human uridine-5'-diphosphoglucuronosyltransferases (UGTs) are the major phase II metabolizing enzymes. In the present study, five human UGTs (UGT1A1, 1A4, 1A6, 2B7, and 2B10) were individually expressed and used to examine the inhibition IC(50) values of 20 selective substrates and inhibitors of major cytochromes P450 (CYPs). The inhibition kinetics of UGT1A1 was also analyzed. The results showed that some compounds like α-naphthoflavone, paclitaxel, midazolam, cyclosporine A, and ketoconazole displayed strong inhibitions on UGT activities with their IC(50) values in a range of 4.1-26 µM. Especially, the IC(50) values were 4.1 ± 0.8 µM for ketoconazole in inhibiting UGT1A1-mediated β-estradiol-3-glucuronidation, and 4.9 ± 0.3 µM for paclitaxel towards UGT1A4-mediated midazolam-N-glucuronidation. Additionally, the IC(50) values of bupropion, tolbutamide, and testosterone in inhibiting UGT-mediated metabolisms were similar with the K(m) values of respective CYPs. Some kinetic behaviours of UGTs were following Michaelis-Menten kinetics, while some were not.

摘要

人尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)是主要的 II 相代谢酶。在本研究中,单独表达了 5 个人 UGT(UGT1A1、1A4、1A6、2B7 和 2B10),并用于检测 20 种主要细胞色素 P450(CYPs)的选择性底物和抑制剂的抑制 IC(50)值。还分析了 UGT1A1 的抑制动力学。结果表明,一些化合物,如α-萘黄酮、紫杉醇、咪达唑仑、环孢素 A 和酮康唑,对 UGT 活性表现出强烈的抑制作用,其 IC(50)值在 4.1-26µM 范围内。特别是酮康唑对 UGT1A1 介导的雌二醇-3-葡糖苷酸化的抑制 IC(50)值为 4.1±0.8µM,紫杉醇对 UGT1A4 介导的咪达唑仑-N-葡糖苷酸化的抑制 IC(50)值为 4.9±0.3µM。此外,丁丙诺啡、甲苯磺丁脲和睾酮抑制 UGT 代谢的 IC(50)值与各自 CYP 的 K(m)值相似。一些 UGT 的动力学行为遵循米氏动力学,而另一些则不遵循。

相似文献

1
The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.人尿苷二磷酸葡萄糖醛酸转移酶与细胞色素 P450 选择性底物和抑制剂的抑制研究。
J Enzyme Inhib Med Chem. 2011 Jun;26(3):386-93. doi: 10.3109/14756366.2010.518965. Epub 2010 Oct 13.
2
Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.UDP对UDP-葡萄糖醛酸基转移酶(UGT)的产物抑制作用掩盖了UGT底物的抑制效果。
Drug Metab Dispos. 2008 Feb;36(2):361-7. doi: 10.1124/dmd.107.018705. Epub 2007 Nov 12.
3
Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.水飞蓟宾使细胞色素P450 3A4和2C9失活,并抑制主要的肝脏葡萄糖醛酸转移酶。
Drug Metab Dispos. 2004 Jun;32(6):587-94. doi: 10.1124/dmd.32.6.587.
4
Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.人尿苷二磷酸葡萄糖醛酸转移酶的底物(三氟拉嗪)和抑制剂(阿米替林、雄甾酮、坎利酮酸、海柯皂苷元、保泰松、奎尼丁、奎宁和磺吡酮)“探针”的选择性。
Drug Metab Dispos. 2006 Mar;34(3):449-56. doi: 10.1124/dmd.105.007369. Epub 2005 Dec 28.
5
Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.优化的人尿苷二磷酸葡萄糖醛酸转移酶(UGT)活性测定法:改变α-鹅膏蕈碱浓度及其用于筛选 UGT 抑制剂的效用。
Drug Metab Dispos. 2012 May;40(5):1051-65. doi: 10.1124/dmd.111.043117. Epub 2012 Feb 22.
6
Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.MAM - 2201对人肝微粒体中细胞色素P450和尿苷5'-二磷酸葡萄糖醛酸转移酶的抑制作用。
Arch Pharm Res. 2017 Jun;40(6):727-735. doi: 10.1007/s12272-017-0917-y. Epub 2017 May 8.
7
Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.人尿苷二磷酸葡萄糖醛酸基转移酶:4-甲基伞形酮和1-萘酚葡萄糖醛酸化的同工型选择性及动力学、有机溶剂的影响以及双氯芬酸和丙磺舒的抑制作用
Drug Metab Dispos. 2004 Apr;32(4):413-23. doi: 10.1124/dmd.32.4.413.
8
The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.人肝微粒体和重组尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)对Δ4-3-酮C19和C21羟基类固醇的葡萄糖醛酸化作用:6α-和21-羟孕酮是UGT2B7的选择性底物。
Drug Metab Dispos. 2007 Mar;35(3):363-70. doi: 10.1124/dmd.106.013052. Epub 2006 Dec 6.
9
Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.N端结构域组氨酸和脯氨酸残基对人尿苷二磷酸葡萄糖醛酸基转移酶1A1、1A6、1A9、2B7和2B10底物选择性的影响
Drug Metab Dispos. 2009 Sep;37(9):1948-55. doi: 10.1124/dmd.109.028225. Epub 2009 Jun 1.
10
Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate glucuronosyltransferases.迷迭香酸与人细胞色素 P450 单加氧酶和尿苷二磷酸葡萄糖醛酸基转移酶的代谢相互作用。
Biomed Pharmacother. 2019 Feb;110:111-117. doi: 10.1016/j.biopha.2018.11.040. Epub 2018 Nov 19.

引用本文的文献

1
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.HSP90抑制剂奥纳莱斯匹布(AT13387)与紫杉醇联合用于晚期三阴性乳腺癌患者的Ib期研究。
Ther Adv Med Oncol. 2023 Dec 25;15:17588359231217976. doi: 10.1177/17588359231217976. eCollection 2023.
2
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.精神科药物与 MDMA 或裸盖菇素之间的药物相互作用:系统评价。
Psychopharmacology (Berl). 2022 Jun;239(6):1945-1976. doi: 10.1007/s00213-022-06083-y. Epub 2022 Mar 7.
3
Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions.
多伟拉韦及其与 CYP3A 介导的药物相互作用的潜力。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02016-18. Print 2019 May.
4
Absorption, Metabolic Stability, and Pharmacokinetics of Ginger Phytochemicals.生姜植物化学物的吸收、代谢稳定性及药代动力学
Molecules. 2017 Mar 30;22(4):553. doi: 10.3390/molecules22040553.
5
Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.细胞色素P450 2D6功能对3,4-亚甲基二氧甲基苯丙胺(摇头丸)及其I相和II相代谢产物在人体血浆中的手性药代动力学的影响。
PLoS One. 2016 Mar 11;11(3):e0150955. doi: 10.1371/journal.pone.0150955. eCollection 2016.
6
Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model.使用基于生理的药代动力学模型通过CYP2D6和CYP3A抑制预测与羟考酮的代谢相互作用。
CPT Pharmacometrics Syst Pharmacol. 2014 Dec 17;3(12):e152. doi: 10.1038/psp.2014.49.
7
A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole.伏立康唑对肝和肠壁细胞色素 P4503A 动态抑制的拟生理群体药代动力学模型。
Clin Pharmacokinet. 2013 Sep;52(9):763-81. doi: 10.1007/s40262-013-0070-9.